SpectraBase Spectrum ID |
JINFeGaarVA |
Name |
Dienogest-A II |
Classification |
Pharmaceutical drug artifact |
Copyright |
Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
DEA Citation |
21 CFR §1308.13 (f) (69) |
DEA Controlled Substance Name |
19-nor-4,9(10)-androstadienedione |
DEA Controlled Substance Type |
Salts, esters and ethers |
DEA Controlled Substances Code Number |
4000 |
DEA Schedule |
Schedule III |
DEA Section |
Anabolic Steroids. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation containing any quantity of the following substances, including its salts, esters and ethers. |
Exact Mass |
270.161979946 u |
Formula |
C18H22O2 |
InChI |
InChI=1S/C18H22O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h10,15-16H,2-9H2,1H3 |
InChIKey |
BHTWZQKERRCPRZ-UHFFFAOYSA-N |
Ionization Type |
Electron Ionization (EI) |
Molecular Weight |
270.372 g/mol |
Nominal Mass |
270 u |
Quality |
901 |
Retention Index |
2072 |
SMILES |
C12(C(C3C(=C4C(CC3)=CC(CC4)=O)CC2)CCC1=O)C |
SPLASH |
splash10-05fr-2940000000-da1aff204fdb1dd51ed3 |
Sample Comments |
Structure uncertain |
Source of Spectrum |
DigiLab GmbH (C) 2024 |
Synonyms |
11a-methyl-2,3,3a,4,5,8,9,10,11,11a-decahydro-1H-cyclopenta[a]phenanthrene-1,7(3bH)-dione |
Technique |
GC/MS |
Wiley ID |
DD2024_007877 |